Inside the Texas Medical Center: 106,000 Workers Across 50 Million SF
Bill McKeon
HOUSTON – (By Michelle Leigh Smith for Realty News Report) – The Texas Medical Center (TMC) is moving beyond bricks and mortar. While nearly $3 billion in new construction is planned over the next decade, an equally important effort focuses on building international collaborations and technological bridges that accelerate access to life-saving treatments. One notable initiative is the TMC–Australia BioBridge, a partnership designed to coordinate research and increase patient access for clinical trials across borders.
“With the advent of artificial intelligence (AI), we have a new tool that will shorten this process from months to minutes,” said Bill McKeon, President and CEO of the Texas Medical Center, at the annual State of the TMC luncheon sponsored by the Greater Houston Partnership.
McKeon explained how AI can learn clinicians’ specialized language and quickly scan patient records to match individuals to appropriate trials. That capability significantly speeds recruitment and improves the efficiency of clinical studies, making it easier to connect patients with promising treatments.
McKeon recently returned from meetings in Australia with Prime Minister Scott Morrison and Health Minister Greg Hunt. The conversations focused on how researchers studying rare cancers and pediatric diseases can more rapidly enroll the necessary number of patients by drawing from a larger, international pool. Cross-border collaboration like the BioBridge expands opportunities for trials that otherwise struggle to recruit enough participants.
Breakthroughs emerging from TMC innovation programs not only boost Houston’s global reputation but also reshape healthcare delivery and extend lives. This year’s program highlighted Nobel Laureate Dr. Jim Allison from M.D. Anderson Cancer Center, whose work on checkpoint blockade immunotherapy has changed oncology. McKeon showed a video in which Allison recalled a patient whose request was simple: help her live long enough to attend her son’s graduation. That patient recently returned for a 10-year follow-up.
To support translation of early-stage ideas into viable medical solutions, the TMC Venture Fund now holds $25 million designated to fill Houston’s early-stage funding gap. These investments focus on helping technologies and startups reach research, operational, and clinical milestones so they can attract later-stage financing. By providing capital and operational support, the fund aims to sustain a local innovation ecosystem where promising companies can grow without relocating to the East or West Coast.
Expansion across the TMC campus includes significant mental health capacity and new academic and research facilities. Harris County has been granted land for a psychiatric hospital with 304 new beds to address severe undercapacity in mental health services. UTMB’s League City campus has added a five-story tower with 60 beds and holds a lease for 191 additional beds in Clear Lake, available in spring 2019.
Today, the Texas Medical Center comprises approximately 50 million developed square feet and maintains about 9,200 patient beds. New educational investments include the University of Houston’s medical school, planned on 43 acres near MLK Boulevard and Old Spanish Trail, designed to serve the surrounding community.
Also slated to open in 2019 is Texas A&M’s Health Science Center on the TMC3 research campus. The project, exceeding 1.5 million square feet, sits on a 30-acre collaborative campus near Bertner and Braeswood. McKeon praised Texas A&M Health Science Center Senior Vice President Carrie Byington for her leadership, noting the campus will be a platform for research and commercialization within the Texas Medical Center.
TMC will leverage partnerships among four of its sixty member institutions—Baylor College of Medicine, Texas A&M University Health Science Center, The University of Texas Health Science Center, and The University of Texas M.D. Anderson Cancer Center—to attract top researchers and build multidisciplinary teams. McKeon described the planned research district as one of the most dynamic areas of the medical city, pointing to renderings of a rooftop park shaped like a double helix visible from the air and new amenities such as a hotel, conference center, restaurants, and retail space.
International collaboration extends beyond Australia. TMC also partners with the U.K. trade department to advance life sciences research and foster commercial alliances. Domestically, the entry of corporate innovation partners—like Johnson & Johnson and AT&T’s The Foundry—brings corporate resources into incubators where new medical devices and solutions are prototyped and piloted. McKeon emphasized the importance of local economic fuel to keep startups in Houston and provide pathways through regulatory and clinical testing.
McKeon joined the Texas Medical Center in 2013 as executive vice president and chief operating and strategy officer and later became President and CEO. Under his leadership, TMC has formed numerous global alliances and partnerships that have driven job growth. The center now supports more than 106,000 jobs, spans 1,345 acres, and contributes roughly $25 billion in GDP, ranking it among the largest business districts in the United States.
Before leading TMC, McKeon held executive roles with major companies and institutions including DuPont, Stanford University Medical Center, Raytel, US Oncology, and Medtronic. He also served as president and CEO of international medical companies MicroPort Medical in Shanghai and Cellnovo in London.
Bob Harvey, president and CEO of the Greater Houston Partnership, opened the luncheon at the Hilton of the Americas, welcoming leaders from Norton Rose Fulbright, AECOM, AT&T, Husch Blackwell, and Rice University’s Jesse Jones School Executive Education. Harvey noted that when he travels globally, the Texas Medical Center often springs to mind as Houston’s defining asset. “There’s a group in Shanghai who want to emulate our model,” he said.
The scale of TMC’s clinical activity is immense: the center tracks roughly 10 million patient encounters each year, including about 750,000 emergency visits, 13,600 heart surgeries, 180,000 total surgeries, and more than 25,000 births annually. These volumes, combined with growing research, educational, and clinical capacity, underscore the Texas Medical Center’s role as a global hub for medical innovation and care.
